Increased MACC1 expression is largely driven by CIN, SCNA gains, and molecular subtypes, potentially determining the molecular risk for metastasis that might serve as a basis for patient-tailored treatment decisions. This evidence concerns the gene MACC1 and cervical squamous intraepithelial neoplasia.